Nearly every clinical psychedelic session — psilocybin, MDMA, ketamine — happens with headphones on. That isn't a comfort detail. A growing body of research treats the music as an active part of the treatment, shaping where the experience goes and, early evidence suggests, how well it works.
The hidden therapist
The phrase comes from research at Imperial College London. In a psilocybin trial for treatment-resistant depression, researchers interviewed patients about the session music and found something striking: whether a patient felt welcomed or conflicted by the music predicted both the depth of their peak experience and how much their depression lifted a week later. The same research group had already shown that LSD measurably amplifies the emotional response to music — listeners reported far more wonder, transcendence, and tenderness than with music alone.
A 2026 review in npj Mental Health Research pushes the point further: music in psychedelic therapy provides temporal structure, emotional containment, and a way to modulate arousal — functions a co-therapist would otherwise serve. The authors argue trials should standardize what the music is for at each point in a session, not which tracks get played.
The arc of a session
Clinical playlists aren't shuffled favorites — they're built to mirror the pharmacology of the drug. A typical structure:
- Onset (first ~30–60 minutes). Calm, grounding, familiar-feeling music while the medicine takes effect. The job is safety, not intensity.
- Ascent. Gradually building emotional and dynamic intensity, tracking the drug's rise.
- Peak. The most powerful music of the day — often orchestral, choral, or unfamiliar instrumental work. Facilitators tend to avoid lyrics in a language the listener understands, which can steer thought instead of supporting it.
- Return. Gentle, warm, increasingly familiar music as the effects fade — a soft landing back into the room.
What clinics actually play
The best-known session soundtrack is the Johns Hopkins psilocybin playlist — about seven hours and forty minutes, curated for the university's psilocybin trials and publicly available on Spotify. It runs from Vivaldi and Brahms through Gregorian chant and singing bowls before resolving into Louis Armstrong and “Here Comes the Sun.”
Musicians have started composing for this context directly. Jon Hopkins wrote the album Music for Psychedelic Therapy for exactly what its title says, and artists like East Forest build long-form pieces designed for ceremony and therapeutic listening. A 2026 systematic review found that while almost every trial uses music, few report what was played — one reason the field is now pushing to treat playlists as a documented part of the protocol.
Adaptive music: software as the third therapist
A fixed playlist can't respond to the person on the couch. That gap produced Wavepaths, a London company founded by Mendel Kaelen — the neuroscientist behind the “hidden therapist” research — whose software generates continuously adaptive session music that a facilitator can steer in real time. It's used in ketamine and psilocybin practices today, and it's the clearest sign that session music is becoming a clinical tool with its own product category.
What to ask a facilitator about music
If you're considering psilocybin therapy in a licensed program, the music is worth a few minutes of your consultation:
- What playlist do you use, and can I hear some of it beforehand?
- Headphones or room speakers — and do I have a choice?
- If a piece of music becomes distressing mid-session, what do you do?
- Can I request my own music, and when would you advise against it?
How a facilitator answers says a lot about how deliberately they run their sessions. You can compare licensed facilitators and service centers in our provider directory.